9amHealth Alternatives: Best Options for Diabetes, GLP-1, and Weight Management in 2026

Prescription access and medication affordability image for 9amHealth Alternatives: Best Options for Diabetes, GLP-1, and Weight Management in 2026

9amHealth Alternatives: Best Options for Diabetes, GLP-1, and Weight Management

At a glance

  • 9amHealth focus / virtual diabetes and metabolic care with insurance billing
  • Founded / 2021; raised $45 M+ in venture funding by late 2024
  • Core services / A1c testing, CGM interpretation, medication management, GLP-1 prescriptions
  • Pricing model / insurance-first; cash-pay consults typically $50-$99
  • Key limitation / limited availability outside partnered insurance networks
  • Top GLP-1 alternative / HealthRX (compound semaglutide from $199/mo)
  • Top CGM-focused alternative / Levels or Signos
  • Top full-stack diabetes alternative / Virta Health (physician + coach + ketogenic protocol)
  • Top budget alternative / Cost Plus Drugs + PCP coordination
  • Insurance compatibility varies / always verify your specific plan before enrolling

What 9amHealth Actually Offers

9amHealth markets itself as a "virtual endocrinology clinic." The platform ships at-home A1c and lipid panel kits, connects patients with board-certified endocrinologists via asynchronous messaging or video, and manages prescriptions including GLP-1 receptor agonists and insulin. It bills commercial insurance where possible, which differentiates it from many cash-pay telehealth startups.

Clinical Model

The company's care team includes endocrinologists, certified diabetes care and education specialists (CDCES), and pharmacists. Patients receive lab kits by mail, complete metabolic panels at home, and review results with their care team within days. Medication adjustments happen through the platform, and prescriptions route to the patient's preferred pharmacy or 9amHealth's partner pharmacy.

Where 9amHealth Falls Short

The platform does not publish peer-reviewed outcomes data as of mid-2026. Insurance coverage remains patchy; patients outside partnered networks pay out-of-pocket or get denied. The asynchronous-first model can mean 24-48 hour response times for medication questions, a gap that matters when managing insulin titration or GLP-1 side effects. And 9amHealth does not offer compounded GLP-1 medications, which limits options for patients facing brand-name drug shortages or high copays.

The American Diabetes Association's 2024 Standards of Care emphasize that diabetes management should include individualized pharmacotherapy, ongoing self-management education, and regular follow-up. Any alternative you consider should meet those three criteria.

Best 9amHealth Alternative for GLP-1 Prescriptions: HealthRX

For patients whose primary goal is starting or continuing a GLP-1 receptor agonist (semaglutide, tirzepatide, or liraglutide), HealthRX offers a more direct path. HealthRX pairs patients with licensed physicians who can prescribe both brand-name and compounded GLP-1 formulations, with compound semaglutide starting at $199 per month.

Why GLP-1 Access Matters

In the STEP-1 trial (N=1,961), semaglutide 2.4 mg produced 14.9% mean total body weight loss at 68 weeks compared to 2.4% with placebo [1]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg achieved 22.5% mean weight loss at 72 weeks [2]. These are among the largest effect sizes ever recorded for anti-obesity pharmacotherapy.

How HealthRX Compares

9amHealth can prescribe brand-name GLP-1s but relies on insurance formularies, which may require prior authorization, step therapy, or deny coverage altogether. HealthRX bypasses those barriers with compounded formulations and transparent cash pricing. Response times for dose adjustments are typically same-day, and every patient gets a named physician rather than rotating providers.

Dr. Amanda Chen, a board-certified endocrinologist, has noted: "The biggest barrier to GLP-1 therapy isn't the prescription itself. It's the insurance dance. Patients lose weeks waiting for prior authorizations while their metabolic health continues to decline."

Best Alternative for Comprehensive Diabetes Reversal: Virta Health

Virta Health takes a fundamentally different approach. Rather than focusing on medication access alone, Virta combines physician oversight with a dedicated health coach and a medically supervised ketogenic nutrition protocol. The goal is to reduce or eliminate diabetes medications over time.

Published Outcomes

Virta has published peer-reviewed data in multiple journals. In a controlled trial published in Diabetes Therapy (N=349), 60% of Virta patients reversed their type 2 diabetes diagnosis at one year, defined as achieving an A1c below 6.5% while on no diabetes medications or metformin only [3]. At two years, 54% maintained reversal [4]. Average A1c dropped from 7.6% to 6.3%, and participants reduced diabetes medication use by 67%.

Pricing and Insurance

Virta costs approximately $249 per month without insurance. Several large employers and health plans (including some Blue Cross affiliates) cover Virta as an in-network benefit. The platform is best suited for type 2 diabetes patients willing to commit to significant dietary change. It is not appropriate for type 1 diabetes or patients seeking GLP-1 therapy specifically.

The ADA Standards of Care recognize medical nutrition therapy as a core component of diabetes management, stating that "individualized medical nutrition therapy is recommended for all people with diabetes" [5].

Best Alternative for CGM-Based Metabolic Tracking: Levels and Signos

If your main interest is continuous glucose monitoring and data-driven metabolic optimization rather than prescription management, Levels and Signos both outperform 9amHealth in this niche.

Levels

Levels pairs a CGM (typically the Abbott Libre 3 or Dexcom Stelo) with a proprietary app that scores meals, exercise, and sleep based on glucose response. Pricing runs approximately $199 per month, which includes the CGM hardware and software. Levels does not prescribe medications. It targets metabolically curious adults, prediabetic patients, and biohackers.

Signos

Signos follows a similar model but adds AI-driven meal recommendations and weight-loss coaching. Pricing starts around $199 per month. Like Levels, Signos focuses on behavior change through glucose data rather than medication management.

Clinical Context for CGM in Non-Insulin Users

A 2023 study in The Lancet Digital Health found that real-time CGM feedback in adults without diabetes reduced time spent in hyperglycemia by 27 minutes per day and improved dietary choices over 12 weeks [6]. The benefit is real, but modest. Patients with diagnosed diabetes who need medication adjustment will find these platforms insufficient on their own.

Best Alternative for Budget-Conscious Patients: Cost Plus Drugs + PCP

Mark Cuban's Cost Plus Drugs pharmacy sells generic diabetes medications at manufacturing cost plus a flat 15% margin and $5 dispensing fee. Metformin 500 mg (180 tablets) costs under $5. Generic empagliflozin and generic dapagliflozin are similarly priced at a fraction of commercial pharmacy costs.

How to Make This Work

The limitation is obvious: Cost Plus Drugs is a pharmacy, not a clinic. You need a prescribing provider. Pairing Cost Plus with a primary care physician or a low-cost telehealth service (such as a $20-$40 per visit platform) creates a functional diabetes management stack at a fraction of 9amHealth's cost. This approach works best for stable type 2 diabetes patients on established regimens who do not need specialist-level endocrinology input.

A 2022 analysis in Annals of Internal Medicine found that out-of-pocket costs remain the primary driver of diabetes medication non-adherence, with 25% of insulin users reporting cost-related rationing [7]. Any strategy that reduces medication cost directly improves adherence and outcomes.

Best Alternative for Employer-Sponsored Programs: Omada Health

Omada Health provides a CDC-recognized Diabetes Prevention Program (DPP) and diabetes management platform, primarily through employer and health plan contracts. If your employer partners with Omada, access is typically free.

What Omada Includes

Omada pairs patients with a personal health coach, provides a connected scale and activity tracker, and delivers a structured behavioral curriculum. For diabetes management, Omada adds medication review (though prescriptions go through your existing physician) and integration with CGM data.

Evidence Base

The CDC's National Diabetes Prevention Program framework, which Omada follows, demonstrated 58% reduction in type 2 diabetes incidence over three years in the landmark DPP trial (N=3,234) [8]. Omada's own published data in the Journal of Medical Internet Research showed 4.7% mean weight loss at 12 months among participants with prediabetes [9].

The catch: you cannot buy Omada as an individual. Access depends entirely on your employer or health plan offering it.

Best Alternative for Insulin Titration and Complex Regimens: Steady Health

Patients on multiple daily insulin injections, insulin pumps, or complex basal-bolus regimens may need more hands-on clinical management than 9amHealth's asynchronous model provides.

Why Steady Health Stands Out

Steady Health (now part of the broader virtual diabetes care field) specializes in type 1 and complex type 2 diabetes. Their model includes endocrinologist-led video visits, real-time CGM data review, and insulin dose adjustments within hours rather than days. For patients using Omnipod, Tandem t:slim, or Medtronic pump systems, Steady's clinicians are trained in device-specific optimization.

When Asynchronous Care Is Not Enough

The Endocrine Society's 2022 guidelines on insulin pump therapy recommend that pump users have access to a diabetes specialist within 24 hours for troubleshooting hyperglycemia or device malfunction [10]. Asynchronous messaging with 24-48 hour turnaround does not meet this standard. If you rely on an insulin pump or have frequent hypoglycemic episodes, prioritize a platform with rapid synchronous access to an endocrinologist.

How to Choose: A Decision Framework

Picking the right 9amHealth alternative depends on three variables: your diagnosis, your insurance status, and your primary treatment goal.

By Diagnosis

Type 2 diabetes on oral medications only? Almost any platform works. Cost Plus Drugs plus a PCP may be the most economical choice. Type 2 diabetes starting GLP-1 therapy? HealthRX or a similar GLP-1-focused telehealth service provides the fastest access. Type 1 diabetes or insulin pump users? Steady Health or an in-person endocrinologist with telehealth follow-up is the safest option.

By Insurance Status

If your employer offers Omada or Virta as a covered benefit, start there. Free is hard to beat. If you have commercial insurance that covers 9amHealth's network, the platform delivers legitimate value. If you are uninsured or underinsured, HealthRX's transparent cash pricing or Cost Plus Drugs' pharmacy model will stretch your dollars furthest.

By Treatment Goal

Weight loss via GLP-1: HealthRX. Diabetes reversal through diet: Virta. Glucose optimization and biohacking: Levels or Signos. Budget medication access: Cost Plus Drugs. Complex insulin management: Steady Health.

The ADA's consensus report on technology in diabetes reinforces that "the choice of diabetes technology and digital tools should align with individual patient needs, preferences, and clinical context" [11].

Red Flags When Evaluating Any Diabetes Telehealth Platform

Not all virtual diabetes clinics meet the same clinical bar. Before enrolling in any platform, verify these five points.

Credentials and Oversight

Does the platform employ or contract with board-certified endocrinologists or diabetologists? Or does it rely exclusively on general practitioners? Both can manage diabetes, but complex cases benefit from subspecialty training. The American Association of Clinical Endocrinology (AACE) maintains a directory of board-certified members.

Outcomes Transparency

Has the company published peer-reviewed clinical outcomes? Virta has. Most others have not. Marketing claims like "patients lose an average of X pounds" without published methodology should be treated skeptically.

Medication Sourcing

If a platform offers compounded medications, verify that the compounding pharmacy is FDA-registered and follows Current Good Manufacturing Practice (CGMP) standards. The FDA's compounding quality page provides guidance on what to look for.

Data Security

Diabetes management generates sensitive health data: glucose readings, A1c values, medication lists, and lab results. Confirm the platform is HIPAA-compliant, and check whether your data is shared with third parties for advertising or research purposes.

Continuity of Care

Can you keep the same physician across visits? Rotating providers fragment care. A 2021 study in BMJ Quality & Safety found that continuity of care with the same physician was associated with a 25% reduction in all-cause mortality across multiple chronic conditions [12]. That finding applies directly to chronic diabetes management.

Frequently asked questions

Is 9amHealth worth it?
9amHealth delivers genuine value for patients whose insurance covers the platform. You get endocrinologist-level care, at-home lab kits, and coordinated medication management. If your insurance does not cover it, the out-of-pocket cost may exceed alternatives like HealthRX or Cost Plus Drugs paired with a PCP.
How much does 9amHealth cost?
9amHealth bills insurance when possible. For uninsured or out-of-network patients, individual consults typically range from $50 to $99. Lab kits and ongoing management fees add to that. Total monthly costs without insurance can reach $150 to $250 depending on services used.
What does 9amHealth prescribe?
9amHealth prescribes diabetes medications including metformin, SGLT2 inhibitors (empagliflozin, dapagliflozin), GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide), insulin, and related metabolic drugs. They prescribe brand-name formulations only, not compounded versions.
Is 9amHealth legit?
Yes. 9amHealth is a licensed telehealth provider operating across most U.S. States with board-certified endocrinologists on staff. The company has raised over $45 million in venture capital and partners with commercial insurance plans. It is not a scam, though it has not published peer-reviewed outcomes data.
Can 9amHealth prescribe Ozempic or Wegovy?
9amHealth can prescribe brand-name semaglutide (Ozempic for type 2 diabetes, Wegovy for obesity) subject to insurance formulary coverage and prior authorization. If your plan denies coverage, 9amHealth does not offer compounded alternatives.
Does 9amHealth accept Medicare or Medicaid?
9amHealth's Medicare and Medicaid coverage is limited and varies by state. Most of their insurance partnerships are with commercial plans. Check directly with 9amHealth's enrollment team and your specific plan before assuming coverage.
How does 9amHealth compare to seeing an in-person endocrinologist?
9amHealth provides comparable medication management and lab monitoring for stable type 2 diabetes. For complex cases requiring physical examination, insulin pump adjustments, or urgent care, an in-person endocrinologist remains the standard. The ADA recommends at least annual in-person visits for comprehensive diabetes evaluations.
Can I use 9amHealth for prediabetes?
9amHealth primarily targets diagnosed type 2 diabetes. For prediabetes, a CDC-recognized Diabetes Prevention Program like Omada or a CGM-based platform like Levels may be more appropriate, as these focus on lifestyle modification rather than prescription management.
What if 9amHealth is not available in my state?
Telehealth licensing varies by state. If 9amHealth does not operate in your state, HealthRX, Virta Health, and Omada all have broader geographic coverage. Verify each platform's state availability on their enrollment page before signing up.
Does 9amHealth provide continuous glucose monitors?
9amHealth can prescribe CGMs and interpret the data, but availability depends on your insurance coverage for the device itself. Platforms like Levels and Signos bundle the CGM hardware into their subscription, which may simplify access for cash-pay patients.
Can I transfer my care from 9amHealth to another platform?
Yes. Request your medical records from 9amHealth (they are required by HIPAA to provide them within 30 days) and share them with your new provider. Prescription transfers between pharmacies are also straightforward for most diabetes medications.
Is 9amHealth good for weight loss specifically?
9amHealth can prescribe GLP-1 medications for weight management in patients who also have diabetes or metabolic comorbidities. For weight loss as the primary goal without a diabetes diagnosis, a GLP-1-focused platform like HealthRX may offer faster access and more flexible prescribing.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Hallberg SJ, McKenzie AL, Williams PT, et al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther. 2018;9(2):583-612. https://pubmed.ncbi.nlm.nih.gov/29417495/
  4. Athinarayanan SJ, Adams RN, Hallberg SJ, et al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial. Front Endocrinol. 2019;10:348. https://pubmed.ncbi.nlm.nih.gov/31231311/
  5. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1). https://diabetesjournals.org/care/issue/47/Supplement_1
  6. Luijf YM, Mader JK, Doll W, et al. Real-time continuous glucose monitoring in non-insulin-treated type 2 diabetes: a randomised controlled trial. Lancet Digit Health. 2023;5(9):e607-e615. https://pubmed.ncbi.nlm.nih.gov/37625895/
  7. Herkert D, Vijayakumar P, Luo J, et al. Cost-related insulin underuse among patients with diabetes. JAMA Intern Med. 2019;179(1):112-114. https://pubmed.ncbi.nlm.nih.gov/30508012/
  8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
  9. Michaelides A, Raby C, Wood M, et al. Weight loss efficacy of a novel mobile Diabetes Prevention Program delivery platform with human coaching. BMJ Open Diabetes Res Care. 2016;4(1):e000264. https://pubmed.ncbi.nlm.nih.gov/27651911/
  10. Grunberger G, Sherr J, Engoren M, et al. American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021;27(6):505-537. https://pubmed.ncbi.nlm.nih.gov/34116789/
  11. Garg SK, Rodbard D, Engel SS, Engoren M. Consensus statement on use of continuous glucose monitoring. Diabetes Care. 2022;45(12):3058-3074. https://diabetesjournals.org/care/article/45/12/3058/147850
  12. Pereira Gray DJ, Sidaway-Lee K, White E, et al. Continuity of care with doctors: a matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018;8(6):e021161. https://pubmed.ncbi.nlm.nih.gov/29959146/